Regulus Therapeutics Inc. Insider Trading for October 2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Regulus Therapeutics Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Regulus Therapeutics Inc. for October 2014.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 31 2014 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Option Exercise | M | 0.38 | 3,505 | 1,332 | 448,287 | |
| Oct 31 2014 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Sell | S | 20.41 | 100 | 2,041 | 2,466 | 2.6 K to 2.5 K (-3.90 %) |
| Oct 31 2014 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Sell | S | 19.78 | 2,005 | 39,659 | 2,566 | 4.6 K to 2.6 K (-43.86 %) |
| Oct 31 2014 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Sell | S | 18.66 | 1,400 | 26,124 | 4,571 | 6 K to 4.6 K (-23.45 %) |
| Oct 31 2014 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Buy | M | 0.38 | 3,505 | 1,332 | 5,971 | 2.5 K to 6 K (+142.13 %) |
| Oct 31 2014 | RGLS | Regulus Therapeuti ... | Gibson Neil W | Chief Scientific Of ... | Option Exercise | M | 1.74 | 2,500 | 4,350 | 114,000 | |
| Oct 31 2014 | RGLS | Regulus Therapeuti ... | Gibson Neil W | Chief Scientific Of ... | Sell | S | 20.41 | 200 | 4,082 | 80,000 | 80.2 K to 80 K (-0.25 %) |
| Oct 31 2014 | RGLS | Regulus Therapeuti ... | Gibson Neil W | Chief Scientific Of ... | Sell | S | 19.67 | 1,200 | 23,604 | 80,200 | 81.4 K to 80.2 K (-1.47 %) |
| Oct 31 2014 | RGLS | Regulus Therapeuti ... | Gibson Neil W | Chief Scientific Of ... | Sell | S | 18.68 | 1,100 | 20,548 | 81,400 | 82.5 K to 81.4 K (-1.33 %) |
| Oct 31 2014 | RGLS | Regulus Therapeuti ... | Gibson Neil W | Chief Scientific Of ... | Buy | M | 1.74 | 2,500 | 4,350 | 82,500 | 80 K to 82.5 K (+3.13 %) |
| Oct 24 2014 | RGLS | Regulus Therapeuti ... | ISIS PHARMACEUTICALS INC | Director | Sell | S | 15.19 | 1,850 | 28,109 | 6,795,716 | 6.8 M to 6.8 M (-0.03 %) |
| Oct 24 2014 | RGLS | Regulus Therapeuti ... | ISIS PHARMACEUTICALS INC | Director | Sell | S | 14.24 | 1,700 | 24,202 | 6,797,566 | 6.8 M to 6.8 M (-0.03 %) |
| Oct 24 2014 | RGLS | Regulus Therapeuti ... | ISIS PHARMACEUTICALS INC | Director | Sell | S | 14.00 | 109,534 | 1,533,125 | 6,799,266 | 6.9 M to 6.8 M (-1.59 %) |
| Oct 24 2014 | RGLS | Regulus Therapeuti ... | ALNYLAM PHARMACEUTICALS, INC. | 10% Owner | Sell | S | 15.19 | 1,850 | 28,109 | 5,896,716 | 5.9 M to 5.9 M (-0.03 %) |
| Oct 24 2014 | RGLS | Regulus Therapeuti ... | ALNYLAM PHARMACEUTICALS, INC. | 10% Owner | Sell | S | 14.24 | 1,700 | 24,202 | 5,898,566 | 5.9 M to 5.9 M (-0.03 %) |
| Oct 24 2014 | RGLS | Regulus Therapeuti ... | ALNYLAM PHARMACEUTICALS, INC. | 10% Owner | Sell | S | 14.00 | 109,534 | 1,533,125 | 5,900,266 | 6 M to 5.9 M (-1.82 %) |
| Oct 22 2014 | RGLS | Regulus Therapeuti ... | Szekeres David Leslie | CBO and General Cou ... | Option Exercise | A | 8.51 | 40,000 | 340,400 | 40,000 | |
| Oct 22 2014 | RGLS | Regulus Therapeuti ... | Gibson Neil W | Chief Scientific Of ... | Option Exercise | A | 6.13 | 40,000 | 245,200 | 40,000 | |
| Oct 24 2014 | RGLS | Regulus Therapeuti ... | Gibson Neil W | Chief Scientific Of ... | Option Exercise | M | 1.74 | 3,300 | 5,742 | 116,500 | |
| Oct 24 2014 | RGLS | Regulus Therapeuti ... | Gibson Neil W | Chief Scientific Of ... | Sell | S | 14.44 | 3,300 | 47,644 | 80,000 | 83.3 K to 80 K (-3.96 %) |
| Oct 24 2014 | RGLS | Regulus Therapeuti ... | Gibson Neil W | Chief Scientific Of ... | Buy | M | 1.74 | 3,300 | 5,742 | 83,300 | 80 K to 83.3 K (+4.13 %) |
| Oct 22 2014 | RGLS | Regulus Therapeuti ... | GRINT PAUL C | Chief Medical Offic ... | Option Exercise | A | 7.58 | 40,000 | 303,200 | 40,000 | |
| Oct 22 2014 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Option Exercise | A | 6.13 | 88,000 | 539,440 | 88,000 | |
| Oct 21 2014 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Option Exercise | M | 0.38 | 300 | 114 | 451,792 | |
| Oct 21 2014 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Option Exercise | M | 0.38 | 400 | 152 | 452,092 | |
| Oct 21 2014 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Sell | S | 7.00 | 300 | 2,100 | 2,466 | 2.8 K to 2.5 K (-10.85 %) |
| Oct 21 2014 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Buy | M | 0.38 | 300 | 114 | 2,766 | 2.5 K to 2.8 K (+12.17 %) |
| Oct 21 2014 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Sell | S | 7.04 | 400 | 2,816 | 2,466 | 2.9 K to 2.5 K (-13.96 %) |
| Oct 21 2014 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Buy | M | 0.38 | 400 | 152 | 2,866 | 2.5 K to 2.9 K (+16.22 %) |
| Oct 17 2014 | RGLS | Regulus Therapeuti ... | ISIS PHARMACEUTICALS INC | Director | Sell | S | 6.79 | 3,000 | 20,371 | 6,908,800 | 6.9 M to 6.9 M (-0.04 %) |
| Oct 17 2014 | RGLS | Regulus Therapeuti ... | ISIS PHARMACEUTICALS INC | Director | Sell | S | 6.76 | 4,800 | 32,450 | 6,911,800 | 6.9 M to 6.9 M (-0.07 %) |
| Oct 17 2014 | RGLS | Regulus Therapeuti ... | ISIS PHARMACEUTICALS INC | Director | Sell | S | 6.67 | 4,300 | 28,687 | 6,916,600 | 6.9 M to 6.9 M (-0.06 %) |
| Oct 17 2014 | RGLS | Regulus Therapeuti ... | ALNYLAM PHARMACEUTICALS, INC. | 10% Owner | Sell | S | 6.79 | 3,000 | 20,371 | 6,009,800 | 6 M to 6 M (-0.05 %) |
| Oct 17 2014 | RGLS | Regulus Therapeuti ... | ALNYLAM PHARMACEUTICALS, INC. | 10% Owner | Sell | S | 6.76 | 4,800 | 32,450 | 6,012,800 | 6 M to 6 M (-0.08 %) |
| Oct 17 2014 | RGLS | Regulus Therapeuti ... | ALNYLAM PHARMACEUTICALS, INC. | 10% Owner | Sell | S | 6.67 | 4,300 | 28,687 | 6,017,600 | 6 M to 6 M (-0.07 %) |
| Oct 14 2014 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Option Exercise | M | 0.38 | 400 | 152 | 452,492 | |
| Oct 14 2014 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Option Exercise | M | 0.38 | 105 | 40 | 452,892 | |
| Oct 14 2014 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Sell | S | 7.00 | 400 | 2,800 | 2,466 | 2.9 K to 2.5 K (-13.96 %) |
| Oct 14 2014 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Buy | M | 0.38 | 400 | 152 | 2,866 | 2.5 K to 2.9 K (+16.22 %) |
| Oct 14 2014 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Sell | S | 7.00 | 105 | 735 | 2,466 | 2.6 K to 2.5 K (-4.08 %) |
| Oct 14 2014 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Buy | M | 0.38 | 105 | 40 | 2,571 | 2.5 K to 2.6 K (+4.26 %) |
| Oct 10 2014 | RGLS | Regulus Therapeuti ... | ISIS PHARMACEUTICALS INC | Director | Sell | S | 6.41 | 2,000 | 12,813 | 6,920,900 | 6.9 M to 6.9 M (-0.03 %) |
| Oct 10 2014 | RGLS | Regulus Therapeuti ... | ISIS PHARMACEUTICALS INC | Director | Sell | S | 6.58 | 4,750 | 31,238 | 6,922,900 | 6.9 M to 6.9 M (-0.07 %) |
| Oct 10 2014 | RGLS | Regulus Therapeuti ... | ISIS PHARMACEUTICALS INC | Director | Sell | S | 6.63 | 3,300 | 21,888 | 6,927,650 | 6.9 M to 6.9 M (-0.05 %) |
| Oct 10 2014 | RGLS | Regulus Therapeuti ... | ALNYLAM PHARMACEUTICALS, INC. | 10% Owner | Sell | S | 6.41 | 2,000 | 12,813 | 6,021,900 | 6 M to 6 M (-0.03 %) |
| Oct 10 2014 | RGLS | Regulus Therapeuti ... | ALNYLAM PHARMACEUTICALS, INC. | 10% Owner | Sell | S | 6.58 | 4,750 | 31,238 | 6,023,900 | 6 M to 6 M (-0.08 %) |
| Oct 10 2014 | RGLS | Regulus Therapeuti ... | ALNYLAM PHARMACEUTICALS, INC. | 10% Owner | Sell | S | 6.63 | 3,300 | 21,888 | 6,028,650 | 6 M to 6 M (-0.05 %) |
| Oct 03 2014 | RGLS | Regulus Therapeuti ... | ISIS PHARMACEUTICALS INC | Director | Sell | S | 6.88 | 3,300 | 22,688 | 6,930,950 | 6.9 M to 6.9 M (-0.05 %) |
| Oct 03 2014 | RGLS | Regulus Therapeuti ... | ISIS PHARMACEUTICALS INC | Director | Sell | S | 6.64 | 3,750 | 24,903 | 6,934,250 | 6.9 M to 6.9 M (-0.05 %) |
| Oct 03 2014 | RGLS | Regulus Therapeuti ... | ISIS PHARMACEUTICALS INC | Director | Sell | S | 6.71 | 3,250 | 21,808 | 6,938,000 | 6.9 M to 6.9 M (-0.05 %) |
| Oct 03 2014 | RGLS | Regulus Therapeuti ... | ALNYLAM PHARMACEUTICALS, INC. | 10% Owner | Sell | S | 6.88 | 3,300 | 22,688 | 6,031,950 | 6 M to 6 M (-0.05 %) |
| Oct 03 2014 | RGLS | Regulus Therapeuti ... | ALNYLAM PHARMACEUTICALS, INC. | 10% Owner | Sell | S | 6.64 | 3,750 | 24,903 | 6,035,250 | 6 M to 6 M (-0.06 %) |
| Oct 03 2014 | RGLS | Regulus Therapeuti ... | ALNYLAM PHARMACEUTICALS, INC. | 10% Owner | Sell | S | 6.71 | 3,250 | 21,808 | 6,039,000 | 6 M to 6 M (-0.05 %) |
| Oct 02 2014 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Option Exercise | M | 0.38 | 2,300 | 874 | 452,997 | |
| Oct 02 2014 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Sell | S | 7.02 | 2,300 | 16,137 | 2,466 | 4.8 K to 2.5 K (-48.26 %) |
| Oct 02 2014 | RGLS | Regulus Therapeuti ... | XANTHOPOULOS KLEANTHIS G | President and CEO | Buy | M | 0.38 | 2,300 | 874 | 4,766 | 2.5 K to 4.8 K (+93.27 %) |